- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 10.27 ↑ 0.39%
[as on 20 October, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|
PGIM India Healthcare Fund - Direct Plan - Growth Option | 0.98% | 0.39% | 2.19% | 1.08% | 1.08% | - | - | - | - | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|
98.30% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.70% |
Equity
Name | Sector | Weight % |
---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 12.26% |
Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 8.40% |
Max Healthcare Institute Ltd. | Healthcare Services | 7.40% |
Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 6.41% |
Aster DM Healthcare Ltd. | Healthcare Services | 6.09% |
Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 5.22% |
JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 4.70% |
Krishna Inst of Medical Sciences Ltd. | Healthcare Services | 3.91% |
Abbott India Ltd. | Pharmaceuticals & Biotechnology | 3.32% |
Global Health Ltd. | Healthcare Services | 3.32% |
Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.27% |
PB Fintech Ltd. | Financial Technology (Fintech) | 2.87% |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 2.82% |
Dr. Lal Path Labs Ltd. | Healthcare Services | 2.81% |
Jupiter Life Line Hospitals Ltd. | Healthcare Services | 2.68% |
Cipla Ltd. | Pharmaceuticals & Biotechnology | 2.59% |
ICICI Lombard General Insurance Co. Ltd. | Insurance | 2.53% |
Neuland Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.36% |
Navin Fluorine International Ltd. | Chemicals & Petrochemicals | 2.30% |
Sai Life Sciences Ltd | Pharmaceuticals & Biotechnology | 2.20% |
IPCA Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.05% |
Rainbow Children's Medicare Ltd. | Healthcare Services | 1.95% |
Sagility Ltd. | IT - Services | 1.78% |
Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | 1.27% |
Orchid Pharma Ltd. | Pharmaceuticals & Biotechnology | 0.79% |
Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 0.73% |
Syngene International Ltd. | Healthcare Services | 0.69% |
Dr Agarwal's Health Care Ltd. | Healthcare Services | 0.58% |
Dr Agarwal's Eye Hospital Ltd. | Healthcare Services | 0.55% |
Blue Jet Healthcare Ltd. | Pharmaceuticals & Biotechnology | 0.45% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
PGIM India Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history
Date | NAV |
---|
20 October, 2025 | 10.27 |
17 October, 2025 | 10.23 |
16 October, 2025 | 10.2 |
15 October, 2025 | 10.03 |
14 October, 2025 | 10.01 |
13 October, 2025 | 10.05 |
10 October, 2025 | 10.04 |
9 October, 2025 | 9.93 |
8 October, 2025 | 9.91 |
7 October, 2025 | 9.9 |
6 October, 2025 | 9.86 |
3 October, 2025 | 9.74 |
1 October, 2025 | 9.74 |
30 September, 2025 | 9.68 |
29 September, 2025 | 9.68 |
26 September, 2025 | 9.71 |
25 September, 2025 | 9.9 |
24 September, 2025 | 9.93 |
23 September, 2025 | 10.02 |
22 September, 2025 | 10.07 |
19 September, 2025 | 10.16 |
18 September, 2025 | 10.08 |
17 September, 2025 | 10.02 |
16 September, 2025 | 10.02 |
15 September, 2025 | 9.99 |
12 September, 2025 | 10.05 |
11 September, 2025 | 10.03 |
10 September, 2025 | 10.02 |
9 September, 2025 | 9.96 |
8 September, 2025 | 9.9 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of PGIM India Healthcare Fund - Direct Plan - Growth Option is 10.27 as on 20 October, 2025.
What are YTD (year to date) returns of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of PGIM India Healthcare Fund - Direct Plan - Growth Option are 0.98% as on 20 October, 2025.